Canopy Immuno-Therapeutics Business
Sector
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Target Customer
Healthcare & Life SciencesLife SciencesBiotechnology
Core Technology
Platforms & InterfacesSoftwareArtificial Intelligence
Tags (11)
biotechnologyinflammatory-diseasesallergytreatmentsartificial-intelligencesoftware-platformlife-sciencesimmunologyimmuno-theraphydrug-developmentimmunotherapy
Canopy Immuno-Therapeutics Financials
Undisclosed
Capital raised
Cumulative Funding Raised Over Time ($)
Canopy Immuno-Therapeutics Lifecycle
Cumulative Funding Raised Over Time
Canopy Immuno-Therapeutics News
1 article
Multi-center nationwide comparison of seven serology assays reveals a SARS-CoV-2 non-responding seronegative subpopulation
Canopy Immuno-Therapeutics Team
Kfir Oved
Founder & CEO
Founder
Galit Denkberg
VP Discovery
Employee Info
| Employees (range) | 1-10 |
| Exact count | 6 |
| Team members | 2 |
Similar Companies
Similar companies data is computed dynamically and not stored in the entity profile. This section requires implementing a similarity query (e.g. by classification overlap, sector, district).
This entity has 9 classification IDs that could be used for matching.